UK Launches Dementia Trials Accelerator to Cut Waiting Times and Speed Up Research
The UK has launched a major initiative to tackle one of the most persistent obstacles in medical research, slow and insufficient enrollment of participants in dementia clinical trials. This problem has delayed the development of new treatments for millions of people affected by neurodegenerative disease, leaving patients and their families facing prolonged uncertainty and emotional…